Presentations will highlight the performance of DBT, AI's promise in reducing false positives in interpreting breast ultrasound images, breast density characterization around the world, microwave imaging in breast cancer, and the effectiveness of including breast density in risk models. The effect of the COVID-19 vaccine on adenopathy and how it relates to breast cancer -- a major story in 2021 -- will also be addressed.
It has been more than 10 years since the first commercially available DBT system was launched. While it may be too early to determine the imaging method's long-term impact on breast screening, that isn't stopping researchers from studying it and comparing it with other imaging modalities. Some presentations at RSNA 2021 even address what happens when AI is applied to DBT imaging.
Speaking of AI, the technology continues to make strides toward being a permanent fixture in clinical practice. Presentations will analyze AI's performance when combined with other imaging methods, as well as the technology's potential to reduce false positives and improve lesion detection.
However, this year's women's imaging presentations are not limited to breast cancer. Researchers will also address topics such as vaginal bleeding from gynecological cysts and how radiation therapy can help, as well as follow-up imaging for ovarian cancer.
In addition, the RSNA will host educational courses that address topics such as AI in breast imaging, minimizing treatment in early breast cancer, the effect of COVID-19 on breast imaging and practice, and imaging in gynecologic oncology, to name a few.
Keep reading for highlights of just some of the many research and poster presentations scheduled for this year's meeting. View the complete 2021 scientific and educational program on the RSNA website.